TrialClinical pharmacology in drug development2021

Pharmacokinetics, Pharmacodynamics, and Safety of the Dual Orexin Receptor Antagonist Lemborexant: Findings From Single-Dose and Multiple-Ascending-Dose Phase 1 Studies in Healthy Adults.

Ishani Landry et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.